Steel Jennifer L, Nadeau Koty, Olek Marion, Carr Brian I
University of Pittsburgh School of Medicine, Starzl Transplantation Institute, Liver Cancer Center, 3459 Fifth Avenue, Montefiore S., Pittsburgh, PA 15213, USA.
J Psychosoc Oncol. 2007;25(3):19-42. doi: 10.1300/J077v25n03_02.
A plethora of research now exists documenting the benefits of psychosocial interventions for cancer patients; however, no studies have been conducted with people diagnosed with hepatobiliary carcinoma.
A total of 28 patients agreed to participate in the study in which 14 patients were randomized to the intervention arm of the study and 14 patients to an attention-standard of care arm. Evaluation of the benefits of the intervention was performed using the Functional Assessment of Cancer Therapy-Hepatobiliary (FACT-Hep), the Center for Epidemiological Studies-Depression, the State Trait Anxiety Index (STAI) to assess anxiety, peripheral blood leukocytes to measure immune system modulation, and survival.
Results indicate that patients who were randomly assigned to the intervention arm of the study reported clinically, but not statistically, significant improvements on symptoms of depression and anxiety, disease-related symptoms and treatment side effects, health-related quality of life (HRQL), and modest improvements in peripheral blood leukocytes and survival when compared with the standard of care group.
The findings of this study suggest that the individually tailored intervention was feasible and preliminary data suggested that the intervention may improve patients' HRQL, mood, and had modest improvements in immune system functioning and survival. Further research is needed with a larger sample size to test the statistical significance and generalizability of the individually tailored intervention.
现在有大量研究记录了心理社会干预对癌症患者的益处;然而,尚未对被诊断为肝胆癌的患者进行过研究。
共有28名患者同意参与该研究,其中14名患者被随机分配到研究的干预组,14名患者被分配到关注标准护理组。使用癌症治疗功能评估-肝胆版(FACT-Hep)、流行病学研究中心抑郁量表、状态特质焦虑量表(STAI)来评估焦虑、外周血白细胞来测量免疫系统调节情况以及生存率,对干预的益处进行评估。
结果表明,与标准护理组相比,被随机分配到研究干预组的患者在抑郁和焦虑症状、疾病相关症状和治疗副作用、健康相关生活质量(HRQL)方面报告了临床上但无统计学意义的显著改善,在外周血白细胞和生存率方面有适度改善。
本研究结果表明,个体化定制的干预是可行的,初步数据表明该干预可能改善患者的HRQL、情绪,并在免疫系统功能和生存率方面有适度改善。需要进一步开展更大样本量的研究,以检验个体化定制干预的统计学意义和普遍性。